Published Date: 02 Mar 2023
A study published online Feb. 27 in JAMA Internal Medicine found that interventions increase prevention but not the association with alcohol use disorder (AUD) in primary care.
Read Full NewsA pair of pediatric epileptologists highlight the systemic and patient level factors driving inequities in infantile epileptic spasms syndrome care and outline paths toward more equitable diagnosis and treatment.
Fenfluramine shows significant seizure reduction in CDKL5 deficiency disorder, offering hope for families facing treatment-resistant epilepsy challenges.
Follow NeurologyLive's conference journey in 2026, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.
A recent analysis reveals fenfluramine's positive effects on executive functioning in adults with Lennox-Gastaut syndrome, independent of seizure reduction.
In a pilot study, liraglutide, a drug used for diabetes and weight-loss, significantly reduced headache days in patients with obesity and chronic or high-frequency migraine, suggesting a potential new preventive therapy.
Q4 2025 Recap: Rheumatology News and Updates
Depression's Implied Bilateral Link With Chronic Kidney Disease Progression
1.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
2.
Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals
3.
Safe and acceptable telehealth suicide prevention program.
4.
Common intracellular toxin could help fight leukemia
5.
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection
3.
The Science Behind Imatinib: How It Targets Cancer Cells
4.
Cemiplimab: A Revolutionary Drug For Treating Cancer
5.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation